Evidence map›Paper›PMID 32070226›Full record

ArticleTissue engineering. Part A2020

A Straightforward Approach to Engineer Vascularized Adipose Tissue Using Microvascular Fragments.

Francisca M Acosta, Katerina Stojkova, Eric M Brey, Christopher R Rathbone

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Engineering Human Beige Adipose Tissue.Frontiers in bioengineering and biotechnology · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Francisca M AcostaDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, Texas.
Katerina StojkovaDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, Texas.
Eric M BreyDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, Texas.
Christopher R RathboneDepartment of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, Texas.
The University of Texas at San Antonio · USThe University of Texas Health Science Center at San Antonio · US

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
Elucidating Skeletal Muscle Satellite Cell:Microvessel Interactions in Diabetic MuscleSC1DK122578 · NIDDK · UNIVERSITY OF TEXAS SAN ANTONIO · PI RATHBONE, CHRISTOPHER RONALD · 2019 to 2022
$1.5M
NIDDK NIH HHS SC1 DK122578NIGMS NIH HHS R25 GM060655
6 · The paper itself

Abstract

There is a need to overcome the donor-site morbidity and loss of volume over time that accompanies the current clinical approaches to treat soft tissue defects caused by disease and trauma. The development of bioactive constructs that can regenerate adipose tissue have made great progress toward addressing the limitations of current therapies, but their lack of vascularization and ability to meet the significant dimension requirements of tissue defects limit their clinical translatability. Microvascular fragments (MVFs) can form extensive vascular networks and contain resident cells that have the ability to differentiate into adipocytes. Therefore, the objective of this study was to determine if vascularized adipose tissue could be engineered using a fibrin-based hydrogel containing MVFs as the sole source of microvessels and adipocyte-forming cells. The potential for MVFs from different fat depots (epididymal, inguinal, and subcutaneous) to form microvascular networks and generate adipocytes when exposed to growth media (GM), adipogenic differentiation media (ADM), or when treated with GM before adipogenic induction (i.e., they were allowed to presprout before adipogenic induction) was evaluated. MVFs treated with adipogenic induction media, both with and without presprouting, contained lipid droplets, had an increase in expression levels of genes associated with adipogenesis (adiponectin and fatty acid synthase [FAS]), and had an increased rate of lipolysis. MVFs allowed to presprout before ADM treatment maintained their ability to form vascular networks while maintaining an elevated lipid content, adipogenic gene expression, and lipolysis rate. Collectively, these results support the contention that MVFs can serve as the sole source of biologic material for creating a vascularized adipose tissue scaffold. Impact statement Microvascular fragments have both the ability to form extensive vascular networks and function as a source of adipocytes. These phenomena were exploited as vascularized adipose tissue was generated by first allowing for a period of angiogenesis before the adipogenic induction. This strategy has the ability to provide a means of both improving soft tissue reconstruction while also serving as a model to better understand adipose tissue expansion.

Indexed as

AdipogenesisAdipose TissueMicrovesselsAdipocytesAnimalsCell DifferentiationMaleRats, Inbred LewTissue Scaffoldsadipogenesisadiposeangiogenesismicrovesselstissue engineering

Identifiers

PMID32070226
PMCPMC7462025
OpenAlexW3006870707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.